VANCOUVER, BC--InphoGene BioCom, a genomics and bioinformatics company here, said it would use Affymetrix's GeneChip to build a series of databases of gene expression information relating to cardiopulmonary disease. The company said it has access to human heart, blood vessel, and lung tissue that will enable it to build internet-based gene expression databases that will be major commercial reference sources for cardiopulmonary disease information. InphoGene will market the databases to pharmaceutical and biotechnology companies, for use alone or in combination with Affymetrix GeneChip probe arrays.
InphoGene Uses GeneChip To Build Online Databases
May 04, 2000